Skip to main content

Table 1 Spearman correlation coefficients of each CSF protein level with patient background and motor symptoms

From: Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson’s disease

 

Patient background

Motor symptoms

  

Age

Education

Duration from symptom onset

UPDRS part III

Tremor

Rigidity

Bradykinesia

Gait

Postural instability

Total αS

r

0.362

0.216

−0.314

− 0.446*

0.192

− 0.331

− 0.528**

− 0.245

−0.356

 

p

0.0635

0.2794

0.1104

0.0289

0.3692

0.1136

0.0080

0.2482

0.0873

 

n

27

27

27

24

24

24

24

24

24

O-αS

r

0.010

−0.036

0.203

−0.205

0.265

− 0.119

−0.224

− 0.335

−0.310

 

p

0.9614

0.8594

0.3105

0.3356

0.2101

0.5792

0.2928

0.1095

0.1407

 

n

27

27

27

24

24

24

24

24

24

Aβ1–42

r

0.292

0.131

−0.231

−0.085

0.140

−0.024

−0.107

− 0.160

−0.047

 

p

0.1389

0.5150

0.2473

0.6913

0.5141

0.9104

0.6203

0.4546

0.8283

 

n

27

27

27

24

24

24

24

24

24

Total tau

r

0.334

0.180

−0.212

−0.297

0.002

−0.195

−0.426*

− 0.167

−0.163

 

p

0.0886

0.3702

0.2877

0.1581

0.9934

0.3610

0.0379

0.4346

0.4457

 

n

27

27

27

24

24

24

24

24

24

P-tau181p

r

0.491*

0.081

−0.032

−0.448*

0.029

−0.425*

−0.462*

− 0.048

−0.338

 

p

0.0126

0.7004

0.8804

0.0365

0.8978

0.0486

0.0303

0.8317

0.1241

 

n

25

25

25

22

22

22

22

22

22

  1. *: p < 0.05, **: p < 0.01
  2. Abbreviations: Total αS, Total α-synuclein; O-αS, Oligomeric α-synuclein; P-tau181p, tau phosphorylated at threonine 181; UPDRS Unified Parkinson’s Disease Rating Scale